Reported Earnings • Apr 17
Third quarter 2026 earnings released: EPS: RM0.017 (vs RM0.017 in 3Q 2025) Third quarter 2026 results: EPS: RM0.017 (in line with 3Q 2025). Revenue: RM446.2m (flat on 3Q 2025). Net income: RM18.3m (up 1.4% from 3Q 2025). Profit margin: 4.1% (up from 4.0% in 3Q 2025). Revenue is forecast to grow 10% p.a. on average during the next 3 years, compared to a 4.0% growth forecast for the Chemicals industry in Malaysia. Over the last 3 years on average, earnings per share has fallen by 14% per year but the company’s share price has only fallen by 7% per year, which means it has not declined as severely as earnings. Board Change • Apr 01
High number of new directors There are 5 new directors who have joined the board in the last 3 years. Independent Non-Executive Director Kamaludin Bin Md Said was the last director to join the board, commencing their role in 2026. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • Jan 21
Second quarter 2026 earnings released: EPS: RM0.017 (vs RM0.014 in 2Q 2025) Second quarter 2026 results: EPS: RM0.017 (up from RM0.014 in 2Q 2025). Revenue: RM428.8m (down 4.9% from 2Q 2025). Net income: RM18.0m (up 19% from 2Q 2025). Profit margin: 4.2% (up from 3.4% in 2Q 2025). The increase in margin was driven by lower expenses. Revenue is forecast to grow 9.7% p.a. on average during the next 3 years, compared to a 4.7% growth forecast for the Chemicals industry in Malaysia. Over the last 3 years on average, earnings per share has fallen by 16% per year but the company’s share price has only fallen by 8% per year, which means it has not declined as severely as earnings. Buy Or Sell Opportunity • Jan 14
Now 22% overvalued Over the last 90 days, the stock has fallen 1.6% to RM0.94. The fair value is estimated to be RM0.77, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 5.0% over the last 3 years. Earnings per share has declined by 17%. Revenue is forecast to grow by 21% in 2 years. Earnings are forecast to grow by 45% in the next 2 years. Buy Or Sell Opportunity • Nov 06
Now 21% overvalued The stock has been flat over the last 90 days, currently trading at RM0.93. The fair value is estimated to be RM0.77, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 5.0% over the last 3 years. Earnings per share has declined by 17%. Revenue is forecast to grow by 21% in 2 years. Earnings are forecast to grow by 45% in the next 2 years. Reported Earnings • Oct 06
Full year 2025 earnings: EPS exceeds analyst expectations while revenues lag behind Full year 2025 results: EPS: RM0.061 (down from RM0.086 in FY 2024). Revenue: RM1.87b (down 6.1% from FY 2024). Net income: RM63.5m (down 22% from FY 2024). Profit margin: 3.4% (down from 4.1% in FY 2024). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 5.2%. Earnings per share (EPS) exceeded analyst estimates by 5.1%. Revenue is forecast to grow 8.9% p.a. on average during the next 2 years, compared to a 4.8% growth forecast for the Chemicals industry in Malaysia. Over the last 3 years on average, earnings per share has fallen by 15% per year but the company’s share price has remained flat, which means it is well ahead of earnings. Tillkännagivande • Sep 29
Ancom Nylex Berhad, Annual General Meeting, Oct 29, 2025 Ancom Nylex Berhad, Annual General Meeting, Oct 29, 2025, at 11:30 Singapore Standard Time. Location: selangor 1 ballroom, dorsett grand subang, jalan ss 12/1, 47500, selangor darul ehsan, subang jaya Malaysia Upcoming Dividend • Jul 30
Upcoming dividend of RM0.01 per share Eligible shareholders must have bought the stock before 06 August 2025. Payment date: 21 August 2025. Payout ratio is a comfortable 16% and this is well supported by cash flows. Trailing yield: 1.1%. Lower than top quartile of Malaysian dividend payers (5.6%). Lower than average of industry peers (3.3%). Reported Earnings • Jul 18
Full year 2025 earnings released: EPS: RM0.061 (vs RM0.086 in FY 2024) Full year 2025 results: EPS: RM0.061 (down from RM0.086 in FY 2024). Revenue: RM1.87b (down 6.1% from FY 2024). Net income: RM63.5m (down 22% from FY 2024). Profit margin: 3.4% (down from 4.1% in FY 2024). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 8.4% p.a. on average during the next 2 years, compared to a 3.3% growth forecast for the Chemicals industry in Malaysia. Over the last 3 years on average, earnings per share has fallen by 15% per year but the company’s share price has increased by 1% per year, which means it is well ahead of earnings. New Risk • Jul 10
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 16% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. This is currently the only risk that has been identified for the company. Reported Earnings • Apr 18
Third quarter 2025 earnings released: EPS: RM0.018 (vs RM0.021 in 3Q 2024) Third quarter 2025 results: EPS: RM0.018 (down from RM0.021 in 3Q 2024). Revenue: RM449.0m (down 13% from 3Q 2024). Net income: RM18.0m (down 10% from 3Q 2024). Profit margin: 4.0% (up from 3.9% in 3Q 2024). The increase in margin was driven by lower expenses. Revenue is forecast to grow 9.0% p.a. on average during the next 3 years, compared to a 3.9% growth forecast for the Chemicals industry in Malaysia. Over the last 3 years on average, earnings per share has fallen by 7% per year and the company’s share price has also fallen by 7% per year. Tillkännagivande • Apr 03
Ancom Nylex Berhad (KLSE:ANCOMNY) acquired 70% stake in Colorex Sdn Bhd from Loke Yeak Thong and Lim Tiak Cheong for MYR 14 million. Ancom Nylex Berhad (KLSE:ANCOMNY) agreed to acquire 70% stake in Colorex Sdn Bhd from Loke Yeak Thong and Lim Tiak Cheong for MYR 14 million on September 19, 2024. A cash consideration of MYR 14 million will be paid by Ancom Nylex Berhad. As part of consideration, MYR 14 million is paid towards common equity of Colorex Sdn Bhd. The transaction will be funded fully through bank borrowings and internally generated fund.
For the period ending December 31, 2023, Colorex Sdn Bhd reported total revenue of MYR 42.96 million and net income of MYR 1.75 million. As of December 31, 2023, Colorex Sdn Bhd reported total common equity of MYR 8.2 million.
The expected completion of the transaction is six months from the agreement date.
Ancom Nylex Berhad (KLSE:ANCOMNY) completed the acquisition of 70% stake in Colorex Sdn Bhd from Loke Yeak Thong and Lim Tiak Cheong on April 2, 2025. All conditions were fulfilled. Buy Or Sell Opportunity • Jan 23
Now 21% overvalued Over the last 90 days, the stock has fallen 3.9% to RM0.99. The fair value is estimated to be RM0.82, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue is forecast to grow by 15% in 2 years. Earnings are forecast to grow by 58% in the next 2 years. Price Target Changed • Jan 18
Price target decreased by 7.6% to RM1.24 Down from RM1.34, the current price target is an average from 4 analysts. New target price is 26% above last closing price of RM0.98. Stock is down 9.6% over the past year. The company is forecast to post earnings per share of RM0.11 for next year compared to RM0.086 last year. Reported Earnings • Jan 17
Second quarter 2025 earnings released: EPS: RM0.014 (vs RM0.023 in 2Q 2024) Second quarter 2025 results: EPS: RM0.014 (down from RM0.023 in 2Q 2024). Revenue: RM450.7m (down 11% from 2Q 2024). Net income: RM15.2m (down 32% from 2Q 2024). Profit margin: 3.4% (down from 4.4% in 2Q 2024). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 7.5% p.a. on average during the next 3 years, compared to a 4.8% growth forecast for the Chemicals industry in Malaysia. Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has fallen by 5% per year, which means it is significantly lagging earnings. Board Change • Dec 01
High number of new directors There are 5 new directors who have joined the board in the last 3 years. Non-Independent & Non-Executive Director Stephan Schnabel was the last director to join the board, commencing their role in 2024. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model. Major Estimate Revision • Nov 20
Consensus EPS estimates fall by 10% The consensus outlook for fiscal year 2025 has been updated. 2025 EPS estimate fell from RM0.098 to RM0.088 per share. Revenue forecast steady at RM2.22b. Net income forecast to grow 38% next year vs 20% growth forecast for Chemicals industry in Malaysia. Consensus price target broadly unchanged at RM1.32. Share price fell 3.7% to RM1.03 over the past week. Reported Earnings • Oct 03
Full year 2024 earnings: EPS and revenues miss analyst expectations Full year 2024 results: EPS: RM0.086 (up from RM0.084 in FY 2023). Revenue: RM2.00b (down 2.3% from FY 2023). Net income: RM81.5m (up 8.4% from FY 2023). Profit margin: 4.1% (up from 3.7% in FY 2023). The increase in margin was driven by lower expenses. Revenue missed analyst estimates by 5.1%. Earnings per share (EPS) also missed analyst estimates by 6.6%. Revenue is forecast to grow 6.5% p.a. on average during the next 3 years, compared to a 6.0% growth forecast for the Chemicals industry in Malaysia. Over the last 3 years on average, earnings per share has increased by 21% per year but the company’s share price has only increased by 6% per year, which means it is significantly lagging earnings growth. Tillkännagivande • Sep 27
Ancom Nylex Berhad, Annual General Meeting, Oct 29, 2024 Ancom Nylex Berhad, Annual General Meeting, Oct 29, 2024, at 15:00 Singapore Standard Time. Location: no. 2a, jalan 13/2, seksyen 13, 46200 petaling jaya, selangor, Malaysia Reported Earnings • Jul 20
Full year 2024 earnings released: EPS: RM0.086 (vs RM0.084 in FY 2023) Full year 2024 results: EPS: RM0.086 (up from RM0.084 in FY 2023). Revenue: RM2.00b (down 2.3% from FY 2023). Net income: RM81.5m (up 8.4% from FY 2023). Profit margin: 4.1% (up from 3.7% in FY 2023). The increase in margin was driven by lower expenses. Revenue is forecast to grow 8.8% p.a. on average during the next 2 years, compared to a 6.6% growth forecast for the Chemicals industry in Malaysia. Over the last 3 years on average, earnings per share has increased by 21% per year but the company’s share price has increased by 29% per year, which means it is tracking significantly ahead of earnings growth. Price Target Changed • Apr 23
Price target decreased by 11% to RM1.41 Down from RM1.59, the current price target is an average from 3 analysts. New target price is 34% above last closing price of RM1.05. Stock is down 2.8% over the past year. The company is forecast to post earnings per share of RM0.085 for next year compared to RM0.084 last year. Reported Earnings • Jan 18
Second quarter 2024 earnings released: EPS: RM0.023 (vs RM0.023 in 2Q 2023) Second quarter 2024 results: EPS: RM0.023 (in line with 2Q 2023). Revenue: RM505.2m (down 4.9% from 2Q 2023). Net income: RM22.1m (up 7.6% from 2Q 2023). Profit margin: 4.4% (up from 3.9% in 2Q 2023). The increase in margin was driven by lower expenses. Revenue is forecast to grow 8.9% p.a. on average during the next 3 years, compared to a 5.2% growth forecast for the Chemicals industry in Malaysia. Over the last 3 years on average, earnings per share has increased by 49% per year but the company’s share price has only increased by 43% per year, which means it is significantly lagging earnings growth. Tillkännagivande • Oct 28
Ancom Nylex Berhad Announces Retirement of CHAN THYE SENG as Non Independent and Non Executive Director Ancom Nylex Berhad announced the Retirement of Mr. CHAN THYE SENG, age 66 as Non Independent and Non Executive Director. Date of change is on October 27, 2023. Mr. Chan Thye Seng did not seek re-election at the 54th Annual General Meeting of the Company which was held 27 October 2023. Reported Earnings • Sep 30
Full year 2023 earnings: EPS and revenues miss analyst expectations Full year 2023 results: EPS: RM0.084. Revenue: RM2.04b (up 1.5% from FY 2022). Net income: RM75.1m (up 10% from FY 2022). Profit margin: 3.7% (up from 3.4% in FY 2022). The increase in margin was driven by higher revenue. Revenue missed analyst estimates by 4.0%. Earnings per share (EPS) also missed analyst estimates by 9.6%. Revenue is forecast to grow 10% p.a. on average during the next 3 years, compared to a 4.0% growth forecast for the Chemicals industry in Malaysia. Tillkännagivande • Sep 27
Ancom Nylex Berhad, Annual General Meeting, Oct 27, 2023 Ancom Nylex Berhad, Annual General Meeting, Oct 27, 2023, at 15:00 Singapore Standard Time. Location: No. 2A, Jalan 13/2, Seksyen 13, 46200 Petaling Jaya SELANGOR DARUL EHSAN Malaysia Agenda: To consider receive the Audited Financial Statements for the financial year ended 31 May 2023 together with the Reports of the Directors and Auditors thereon; to consider re-election of Directors; to approve the payment of Non-Executive Directors' fees for the financial year ended 31 May 2023; to consider approve the payment of Non-Executive Directors' fees for the financial year ending 31 May 2024; to consider approve the payment of Directors' benefits to the Non-Executive Directors; to consider re-appoint Messrs BDO PLT as Auditors of the Company and to authorise the Directors to fix their remuneration; and to consider other matters. Upcoming Dividend • Aug 03
Upcoming dividend of RM0.01 per share at 1.0% yield Eligible shareholders must have bought the stock before 10 August 2023. Payment date: 30 August 2023. Trailing yield: 1.0%. Lower than top quartile of Malaysian dividend payers (5.3%). Lower than average of industry peers (5.8%). Reported Earnings • Jul 15
Full year 2023 earnings released: EPS: RM0.084 (vs RM0.09 in FY 2022) Full year 2023 results: EPS: RM0.084. Revenue: RM2.04b (up 1.5% from FY 2022). Net income: RM75.1m (up 10% from FY 2022). Profit margin: 3.7% (up from 3.4% in FY 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 11% p.a. on average during the next 2 years, compared to a 3.1% growth forecast for the Chemicals industry in Malaysia. Tillkännagivande • Jul 15
Ancom Nylex Berhad Declares First Interim Dividend for the Financial Year Ended May 31, 2023 Payable on 30 August 2023 Ancom Nylex Berhad declared first interim dividend of 1.0 sen per share for the financial year ended May 31, 2023 payable on 30 August 2023. Ex-Date is 10 August 2023. Entitlement date is 11 August 2023. Price Target Changed • Jul 11
Price target increased by 11% to RM1.65 Up from RM1.49, the current price target is an average from 3 analysts. New target price is 73% above last closing price of RM0.95. Stock is up 10% over the past year. The company is forecast to post earnings per share of RM0.08 for next year compared to RM0.09 last year. Reported Earnings • Apr 19
Third quarter 2023 earnings released: EPS: RM0.018 (vs RM0.02 in 3Q 2022) Third quarter 2023 results: EPS: RM0.018. Revenue: RM483.9m (down 5.1% from 3Q 2022). Net income: RM16.4m (up 8.0% from 3Q 2022). Profit margin: 3.4% (up from 3.0% in 3Q 2022). The increase in margin was driven by lower expenses. Revenue is forecast to grow 8.6% p.a. on average during the next 3 years, compared to a 3.4% growth forecast for the Chemicals industry in Malaysia. Tillkännagivande • Jan 18
Ancom Nylex Berhad Announces the Redesignation of MISS CHRISTINA FOO as Independent and Non Executive Chairman of Audit Committee Ancom Nylex Berhad announced the redesingation of MISS CHRISTINA FOO as Independent and Non Executive Chairman of Audit Committee from Independent and Non Executive Member of Audit Committee. Age: 62. Date of change is 17 Jan. 2023. Composition of Audit Committee (Name and Directorate of members after change): Chairman:- Christina Foo (Independent Non-Executive Director); Members:- Tan Sri Dato' Seri Abdull Hamid Bin Embong (Independent Non-Executive Director); Tan Sri Dato' Sri Mohamad Fuzi Bin Harun (Independent Non-Executive Director). Reported Earnings • Jan 18
Second quarter 2023 earnings released: EPS: RM0.023 (vs RM0.016 in 2Q 2022) Second quarter 2023 results: EPS: RM0.023 (up from RM0.016 in 2Q 2022). Revenue: RM531.3m (flat on 2Q 2022). Net income: RM20.6m (up 70% from 2Q 2022). Profit margin: 3.9% (up from 2.3% in 2Q 2022). Revenue is forecast to grow 8.0% p.a. on average during the next 3 years, compared to a 5.5% growth forecast for the Chemicals industry in Malaysia. Over the last 3 years on average, earnings per share has increased by 92% per year but the company’s share price has only increased by 73% per year, which means it is significantly lagging earnings growth. Board Change • Nov 16
High number of new directors There are 5 new directors who have joined the board in the last 3 years. Independent Non-Executive Director Christina Foo was the last director to join the board, commencing their role in 2022. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model. Board Change • Nov 01
High number of new directors There are 5 new directors who have joined the board in the last 3 years. Independent Non-Executive Director Christina Foo was the last director to join the board, commencing their role in 2022. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model. Board Change • Oct 02
High number of new directors There are 5 new directors who have joined the board in the last 3 years. Independent Non-Executive Director Christina Foo was the last director to join the board, commencing their role in 2022. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • Sep 30
Full year 2022 earnings released: EPS: RM0.09 (vs RM0.033 in FY 2021) Full year 2022 results: EPS: RM0.09 (up from RM0.033 in FY 2021). Revenue: RM2.01b (up 31% from FY 2021). Net income: RM68.2m (up 187% from FY 2021). Profit margin: 3.4% (up from 1.5% in FY 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 75% per year but the company’s share price has increased by 85% per year, which means it is tracking significantly ahead of earnings growth. Tillkännagivande • Sep 29
Ancom Nylex Berhad, Annual General Meeting, Oct 27, 2022 Ancom Nylex Berhad, Annual General Meeting, Oct 27, 2022, at 14:30 Singapore Standard Time. Agenda: To receive the Audited Financial Statements for the financial year ended May 31, 2022 together with the Reports of the Directors and Auditors thereon; to approve the payment of Non-Executive Directors' fees for the financial year ended May 31, 2022; to approve the payment of Directors' benefits for the Non-Executive Directors from the date of the forthcoming AGM until the next annual general meeting of the Company; to re-appoint Messrs BDO PLT as Auditors of the Company and to authorize the Directors to fix their remuneration; and to consider other matters. Reported Earnings • Jul 19
Full year 2022 earnings released: EPS: RM0.27 (vs RM0.033 in FY 2021) Full year 2022 results: EPS: RM0.27 (up from RM0.033 in FY 2021). Revenue: RM2.01b (up 31% from FY 2021). Net income: RM68.2m (up 187% from FY 2021). Profit margin: 3.4% (up from 1.5% in FY 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 107% per year but the company’s share price has only increased by 77% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Jun 01
Investor sentiment deteriorated over the past week After last week's 66% share price decline to RM1.05, the stock trades at a trailing P/E ratio of 6.9x. Average trailing P/E is 13x in the Chemicals industry in Malaysia. Total returns to shareholders of 138% over the past three years. Reported Earnings • Apr 21
Third quarter 2022 earnings released: EPS: RM0.061 (vs RM0.03 in 3Q 2021) Third quarter 2022 results: EPS: RM0.061 (up from RM0.03 in 3Q 2021). Revenue: RM510.0m (up 31% from 3Q 2021). Net income: RM15.1m (up 114% from 3Q 2021). Profit margin: 3.0% (up from 1.8% in 3Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 51% per year but the company’s share price has increased by 100% per year, which means it is tracking significantly ahead of earnings growth. Tillkännagivande • Mar 30
Ancom Berhad Appoints Lee Cheun Wei as Executive Managing Director Ancom Berhad appointed Mr. Lee Cheun Wei as Executive Managing Director, Date of change 29 March 2022. Mr. Lee is a member of the Association of Chartered Certified Accountants (ACCA) and the Malaysian Institute of Accountants (MIA). Reported Earnings • Jan 19
Second quarter 2022 earnings: Revenues and EPS in line with analyst expectations Second quarter 2022 results: EPS: RM0.049 (up from RM0.026 in 2Q 2021). Revenue: RM532.9m (up 49% from 2Q 2021). Net income: RM12.1m (up 95% from 2Q 2021). Profit margin: 2.3% (up from 1.7% in 2Q 2021). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has increased by 96% per year, which means it is tracking significantly ahead of earnings growth. Reported Earnings • Oct 04
Full year 2021 earnings released: EPS RM0.10 (vs RM0.043 loss in FY 2020) The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: RM1.54b (up 4.5% from FY 2020). Net income: RM23.8m (up RM33.4m from FY 2020). Profit margin: 1.5% (up from net loss in FY 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 46% per year but the company’s share price has increased by 60% per year, which means it is well ahead of earnings. Valuation Update With 7 Day Price Move • Oct 01
Investor sentiment improved over the past week After last week's 19% share price gain to RM2.30, the stock trades at a trailing P/E ratio of 23.5x. Average trailing P/E is 18x in the Chemicals industry in Malaysia. Total returns to shareholders of 304% over the past three years. Valuation Update With 7 Day Price Move • Sep 17
Investor sentiment improved over the past week After last week's 21% share price gain to RM1.82, the stock trades at a trailing P/E ratio of 18.6x. Average trailing P/E is 17x in the Chemicals industry in Malaysia. Total returns to shareholders of 225% over the past three years. Reported Earnings • Jul 31
Full year 2021 earnings released: EPS RM0.10 (vs RM0.043 loss in FY 2020) The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: RM1.54b (up 4.5% from FY 2020). Net income: RM23.9m (up RM33.6m from FY 2020). Profit margin: 1.6% (up from net loss in FY 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 46% per year but the company’s share price has increased by 33% per year, which means it is well ahead of earnings. Is New 90 Day High Low • Mar 01
New 90-day high: RM1.37 The company is up 73% from its price of RM0.79 on 01 December 2020. The Malaysian market is up 3.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 9.0% over the same period. Is New 90 Day High Low • Feb 09
New 90-day high: RM1.17 The company is up 43% from its price of RM0.82 on 11 November 2020. The Malaysian market is up 3.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 9.0% over the same period. Reported Earnings • Jan 27
Second quarter 2021 earnings released: EPS RM0.026 (vs RM0.006 in 2Q 2020) The company reported a decent second quarter result with improved earnings and profit margins, although revenues were weaker. Second quarter 2021 results: Revenue: RM357.3m (down 10% from 2Q 2020). Net income: RM6.19m (up 394% from 2Q 2020). Profit margin: 1.7% (up from 0.3% in 2Q 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 67% per year but the company’s share price has increased by 30% per year, which means it is well ahead of earnings. Is New 90 Day High Low • Jan 13
New 90-day high: RM1.10 The company is up 40% from its price of RM0.79 on 15 October 2020. The Malaysian market is up 5.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is flat over the same period. Is New 90 Day High Low • Dec 16
New 90-day high: RM0.86 The company is up 1.0% from its price of RM0.85 on 17 September 2020. The Malaysian market is up 9.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 35% over the same period. Reported Earnings • Oct 28
First quarter earnings released Over the last 12 months the company has reported total losses of RM7.32m, with earnings decreasing by RM16.1m from the prior year. Total revenue was RM1.41b over the last 12 months, down 24% from the prior year.